HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


VMS Industry Wants Into CBD Market, Plus Enforcement On Firms Already There

Executive Summary

FDA policy change making hemp and CBD eligible for use a dietary ingredients should include requiring regulatory compliance by companies already marketing products with the ingredients, representatives of firms and industry trade groups said at public hearing. Requirements include submitting to FDA pre-market notifications of proof of a reasonable expectation safety for an ingredient's intended use. "Ensure the rule of law is upheld by barring any company illegally marketing CBD or hemp-derived dietary ingredients from submitting an NDI for the period of time that their products have been illegally marketed," says NOW Health exec Aaron Secrist.

You may also be interested in...

BioMedican Pitches Cannabinoid Biosynthesis Investing; Cultivated Market Sprouts More Deals

BioMedican needs support until it can begin generating revenues and conduct an IPO. Businesses already marketing cannabinoid supplements receive more funding, or in some cases are acquired, as well as expand distribution.

Legislating Hemp As Dietary Ingredient: Wrapping US Market In A Bow, Or Tying DSHEA In Knots?

House legislation to exempt hemp-derived cannabinoids from FDA rule that an “article” previously studied or approved for use as drugs is not allowed for use in dietary supplements either resolves a conundrum or raises additional questions for the agency and the industry.

Congress Ready To Propose Legislation To Deliver US FDA’s Wish: Allowing CBD Use In Supplements

House Energy and Commerce members are expected soon to introduce a bill to make lawful the use of CBD and other hemp-derived ingredients, other than THC, in dietary supplements. Capitol Hill interest in proposing legislation, says Sen. Wyden , will grow if FDA doesn’t bring some order to the CBD space.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts